Parkinsons Disease (PD) Drugs Market Globally Grow at a CAGR of 3.81% by Revenue During the Forecast Period 2017-2021
ResearchMoz presents professional and in-depth study of "Global Parkinsons Disease (PD) Drugs Market 2017-2021".
Parkinsons disease (PD) is a progressive neurodegenerative disorder characterized by damage to the dopaminergic neurons located in various parts of the brain, including the substantia nigra.
Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1307160
This lowers the concentration of dopamine in the striatum by 80%. This decrease in dopamine levels leads to symptoms associated with PD such as tremors, bradykinesia, and muscular rigidity. It is usually diagnosed after the age of 50 years; however, cases of earlier incidence have also been reported.
Technavios analysts forecast the global parkinson's disease (PD) drugs market to grow at a CAGR of 3.81% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global parkinson's disease (PD) drugs market for 2017-2021. To calculate the market size, the report considers sales/revenues and market share of the PD drugs.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
View Complete TOC with tables & Figures @ https://www.researchmoz.us/global-parkinsons-disease-pd-drugs-market-2017-2021-report.html/toc
Technavio's report, Global Parkinson's Disease (PD) Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical Industries
Other prominent vendors
AbbVie
Abital Pharma
Addex Therapeutics
Biogen
Eisai
Eli Lilly
F. Hoffmann-La Roche
H. Lundbeck
Impax Laboratories
Kyowa Hakko Kirin
Otsuka Pharmaceutical
Pfizer
Prana Biotechnology
Reviva Pharmaceuticals
SK Biopharmaceuticals
Takeda Pharmaceutical
UCB
Market driver
Rise in geriatric population
For a full, detailed list, view our report
Market challenge
Entry of generics
For a full, detailed list, view our report
Market trend
Emergence of biomarkers
For a full, detailed list, view our report
Browse Report @ https://www.researchmoz.us/global-parkinsons-disease-pd-drugs-market-2017-2021-report.html
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/
Parkinsons disease (PD) is a progressive neurodegenerative disorder characterized by damage to the dopaminergic neurons located in various parts of the brain, including the substantia nigra.
Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1307160
This lowers the concentration of dopamine in the striatum by 80%. This decrease in dopamine levels leads to symptoms associated with PD such as tremors, bradykinesia, and muscular rigidity. It is usually diagnosed after the age of 50 years; however, cases of earlier incidence have also been reported.
Technavios analysts forecast the global parkinson's disease (PD) drugs market to grow at a CAGR of 3.81% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global parkinson's disease (PD) drugs market for 2017-2021. To calculate the market size, the report considers sales/revenues and market share of the PD drugs.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
View Complete TOC with tables & Figures @ https://www.researchmoz.us/global-parkinsons-disease-pd-drugs-market-2017-2021-report.html/toc
Technavio's report, Global Parkinson's Disease (PD) Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical Industries
Other prominent vendors
AbbVie
Abital Pharma
Addex Therapeutics
Biogen
Eisai
Eli Lilly
F. Hoffmann-La Roche
H. Lundbeck
Impax Laboratories
Kyowa Hakko Kirin
Otsuka Pharmaceutical
Pfizer
Prana Biotechnology
Reviva Pharmaceuticals
SK Biopharmaceuticals
Takeda Pharmaceutical
UCB
Market driver
Rise in geriatric population
For a full, detailed list, view our report
Market challenge
Entry of generics
For a full, detailed list, view our report
Market trend
Emergence of biomarkers
For a full, detailed list, view our report
Browse Report @ https://www.researchmoz.us/global-parkinsons-disease-pd-drugs-market-2017-2021-report.html
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/
Comments
Post a Comment